Development and Characterization of Monovalent and Bivalent RNA Aptamers Targeting the Common Pathway of Coagulation
<p>Anticoagulant agents are commonly used drugs to reduce blood coagulation in acute and chronic clinical settings. Many of these drugs target the common pathway of coagulation because it is critical for thrombin generation and disruption of this portion of the pathway has profound effects on...
Main Author: | Soule, Erin Elizabeth |
---|---|
Other Authors: | Sullenger, Bruce A |
Published: |
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10161/12224 |
Similar Items
-
Development of RNA Aptamers and Antidotes as Antithrombotic Therapeutics
by: Bompiani, Kristin
Published: (2012) -
Targeting the Intrinsic Pathway of Coagulation with RNA Aptamers
by: Woodruff, Rebecca Smock
Published: (2013) -
Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors
by: Max Liu, et al.
Published: (2021-04-01) -
Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
by: Toru Yoshitomi, et al.
Published: (2021-07-01) -
The Evaluation of Pharmacodynamics and Pharmacokinetics of Anti-thrombin DNA Aptamer RA-36
by: Elena Zavyalova, et al.
Published: (2017-12-01)